[ORGANIZATION]
City Therapeutics
Featured in 1 tracked story · first seen
Situations
US biotechnology sector IPO activity
2 clusters · 3 sources · last updated
Latest: Lycia Therapeutics sees successful NASDAQ debut
Biotechnology companies have begun pursuing initial public offerings (IPOs) to fund clinical development despite market uncertainty. City Therapeutics, a Massachusetts-based firm specializing in RNA-based rare disease